arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 1411.0919stat.AP
收藏

推论统计、功效估计和研究设计手续继续抑制生物医学创新

Inferential statistics, power estimates, and study design formalities continue to suppress biomedical innovation

Scott E. Kern

摘要:

创新是研究中某些风格的直接预期产物,而不是其他风格。几十年来,描述性与推理性统计、演绎性与归纳性假设检验、探索性与预先计划的验证性研究设计之间的根本冲突一直在上演,赢家和输家以及后果。来自学术界和研究基金利益集团的长期警告未能有效影响这些斗争的进程。10年前,NIH公开研究和诊断了这个问题的重要方面,导致了拨款审查过程的外部变化,但没有明确的纠正。具体的改革可以有意减轻当前对推论统计、功效估计和规定性研究设计的过度关注所造成的损害。这种改革将允许将资源重新分配给历史上富有成效的快速探索工作,并大大增加产生更大影响的研究发现的机会。我们可以从这些冲突的历史和基础中获益,为管理目标和研究经费决策中的同行评议过程提出具体建议。(C)2013 S.克恩

英文摘要:

Innovation is the direct intended product of certain styles in research, but not of others. Fundamental conflicts between descriptive vs inferential statistics, deductive vs inductive hypothesis testing, and exploratory vs pre-planned confirmatory research designs have been played out over decades, with winners and losers and consequences. Longstanding warnings from both academics and research-funding interests have failed to influence effectively the course of these battles. The NIH publicly studied and diagnosed important aspects of the problem a decade ago, resulting in outward changes in the grant review process but not a definitive correction. Specific reforms could deliberately abate the damage produced by the current overemphasis on inferential statistics, power estimates, and prescriptive study design. Such reform would permit a reallocation of resources to historically productive rapid exploratory efforts and considerably,increase the chances for higher-impact research discoveries. We can profit from the history and foundation of these conflicts to make specific recommendations for administrative objectives and the process of peer review in decisions regarding research funding. (C) 2013 S. Kern

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑